I’ve often wondered just how blind a study could be when a large percentage of the dosing is done in a communist country. Someone in China would know the effects of 208 on the patients as they unfold. And if an official/doctor/scientist etc... in China knows, their government would know (if they wanted to know). This is why I was so exited to see Hepalink (a huge Chinese company) reinvest in Resverlogix to a tune of $86 million was it?
All in my opinion of course.
regards
DND